EMA — authorised 20 January 2013
- Application: EMEA/H/C/002498
- Marketing authorisation holder: Novo Nordisk A/S
- Local brand name: Tresiba
- Indication: Treatment of diabetes mellitus in adults.
- Status: approved
🇪🇺 Insulin degludec 100 U/mL in European Union
EMA authorised Insulin degludec 100 U/mL on 20 January 2013
Marketing authorisation
Other Diabetes approved in European Union
Frequently asked questions
Is Insulin degludec 100 U/mL approved in European Union?
Yes. EMA authorised it on 20 January 2013.
Who is the marketing authorisation holder for Insulin degludec 100 U/mL in European Union?
Novo Nordisk A/S holds the EU marketing authorisation.